Company intelligence / Profile preview

C16 Biosciences

New York City, New York, United Statesc16bio.com ↗

Ownership: Private
Employees: ~30
Development stage: Other

Overview

The company has developed a proprietary fermentation-based process to create Palmless™, a bio-manufactured oil that serves as an alternative to palm oil. Their first product sold out rapidly in the beauty sector and they are expanding into food applications. Clinical results are not relevant as this company does not develop therapeutics.

Industry: Non-Drug Biotech

Partnerships

Collaborations with leading brands/manufacturers in beauty, personal care, home care, and food sectors

Beyond the preview

Go deeper on C16 Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C16 Biosciences.

Explore the full profile